Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oregon for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oregon only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oregon (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Stephen Williams (NPI 1437370947)

Field	Value
Entity Type	Individual
Organization	Stephen Williams
Address	2880 Nw Stewart Parkway
City	Roseburg
State	OR
ZIP	97471
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	May 1, 2007

Payer Source	Total Paid
Medicare	$1.3M
Medicaid	$0

Key Findings

This provider generates $1.3M in lifetime Medicare revenue and has no Medicaid billing on file, making its public payer footprint effectively single-payer Medicare. The profile is highly concentrated: the precomputed top-3 Medicare codes account for 87.4% of this provider's total Medicare revenue, indicating revenue is driven by a narrow set of oncology drug and supportive-care codes.

The practice appears to be an infusion-focused oncology operation centered on high-cost biologic therapy and supportive agents. J9271 (injection, pembrolizumab, 1 mg) is the dominant line-item at $860K (64.3% of Medicare revenue) and is complemented by J0897 (denosumab, 1 mg) at $220.3K and Q5122 (pegfilgrastim-apgf biosimilar) at $88.3K, consistent with an oncology service line that delivers immunotherapy, bone-modifying therapy, and growth-factor support.

Revenue concentration is extreme around the single drug J9271: J9271 alone represents $860K (64.3%), with the next two codes J0897 ($220.3K, 16.5%) and Q5122 ($88.3K, 6.6%) making up the remainder of the 87.4% top-3 share. This pattern shows heavy dependence on a small set of injectable biologics for Medicare revenue rather than on evaluation-and-management or ancillary services.

Competitive standing varies by code. For J9271 the provider ranks #396 of 1841 nationally (78th percentile; typical, unremarkable volume), indicating a modest national presence for pembrolizumab administration; J0897 ranks #801 of 10057 (92th percentile; typical, unremarkable volume), reflecting relatively high national volume for denosumab; and Q5122 ranks #17 of 239 (93th percentile; typical, unremarkable volume), placing the provider among higher-volume users of this pegfilgrastim biosimilar.

Several administration and infusion codes show operational intensity beyond routine levels. Code 96374 (rapid IV push administration) has 347 claims and $10.1K revenue and ranks #55 of 2539 nationally (98th percentile; notably above typical national volume), and 96372 (IM/subcutaneous injection) shows 362 claims and $4K revenue at the 95th percentile — both suggesting substantial throughput for medication administration workflows in the clinic.

Evaluation-and-management (E/M) activity is present but smaller as a revenue driver: 99214 (304 claims, $28K, 2.1% of Medicare revenue) and 99215 (179 claims, $24.5K, 1.8%) represent ongoing outpatient management, but combined they are far overshadowed by drug and infusion revenues. This mix implies the practice bills for routine oncology follow-up and complex visits while relying on drug administration as the primary revenue engine.

The NPI was enumerated on 2007-05-01 (~19 years ago), indicating long tenure in Medicare billing which can reflect an established referral base and operational history. Long enumeration together with concentrated oncology drug volume suggests an entrenched infusion practice rather than a recently transitioned or experimental service model.

Operational and payer risk considerations: with $1.3M concentrated in a few high-cost injectable drugs and no Medicaid revenue, the provider is exposed to changes in Medicare reimbursement or utilization of those specific agents. The absence of Medicaid billing on file further means limited diversification across public payers, which could amplify the financial impact of any policy or utilization shifts affecting these top oncology drugs.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

28 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	20,000	$40	$860K
J0897	Injection, denosumab, 1 mg	12,240	$20	$220.3K
Q5122	Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg	960	$90	$88.3K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	500	$100	$50.9K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	300	$90	$28K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	180	$140	$24.5K
96374	The provider administers a single medication or other substance rapidly into a vein to treat, prevent, or diagnose a condition.	350	$30	$10.1K
96417	In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy…	160	$50	$7.8K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	40	$170	$7.5K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	110	$60	$6.5K

Showing 1–10 of 28

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 28 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oregon Distribution

Stephen Williams — 6 of 24 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oregon

Full comparison — all codes billed, vs. state median

28 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	3	30	8,700	$40	$430.9K
J0897	4	70	2,400	$20	$78.3K
Q5122	1	10	850	$90	$76.2K
J3490	17	50	40	$640	$42.9K
96413	6	90	150	$100	$18.2K
99214	680	6,070	80	$70	$10.3K
99215	133	2,170	40	$100	$6.7K
Q0138	4	20	13,770	$1	$6.2K
96365	26	110	70	$50	$5.8K
99213	1,501	5,480	60	$50	$5.7K

Showing 1–10 of 28

Related Providers

Other providers that share a Tax Identification Number (TIN) with Stephen Williams, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Joshua Weese	OR	Hematology & Oncology Physician	$552.2K	$0
Sara Ray	OR	Family Nurse Practitioner	$162K	$0
Valerie Cooper	OR	Nurse Practitioner	$82.1K	$0

Nearby Providers

Other providers in the same ZIP code as Stephen Williams, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Commonspirit Oregon	OR	General Acute Care Hospital	$0	$29.3M
Centennial Medical Group East, LLC	OR	Rural Health Clinic/Center	$0	$15.3M
Roseburg Therapy LLC	OR	Mental Health Counselor	$0	$14.2M
Rick's Medical Supply, LLC	OR	Durable Medical Equipment & Medical Supplies	$0	$9.6M
Cep America LLC	OR	Emergency Medicine Physician	$0	$4.5M
Humberto Villalvazo	OR	Family Medicine Physician	$4.3M	$0
Liann W Drechsel Dmd PC	OR	Pediatric Dentistry	$0	$3.9M
Centennial Medical Group Inc.	OR	Surgery Physician	$0	$3.8M
Cow Creek Band Of Umpqua Tribe Of Indians	OR	Federally Qualified Health Center (FQHC)	$0	$3.4M
Valley View Mental Health Services, Inc	OR	Professional Counselor	$0	$3.1M

Stephen Williams — Billing Profile & Reimbursement Data

Sign up for Stephen Williams — Billing Profile & Reimbursement Data policy alerts

Stephen Williams — Billing Profile & Reimbursement Data

Sign up for Stephen Williams — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References